Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/49BA stock hub

FRA/49BA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/49BAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

29.5B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/49BA

In the news

Latest news · FRA/49BA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E42.7

P25 n/aP50 n/aP75 n/a

Trailing P/E66.3

P25 n/aP50 n/aP75 n/a

ROE12.4

P25 n/aP50 n/aP75 n/a

ROIC53.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/49BA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	DE
Employees	12,000
Employees Change	400%
Employees Change Percent	3.77
Enterprise value	EUR 26.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 29.5B
Price	EUR 270
Price currency	EUR
Rev Per Employee	414,800.1x
Sic	2836
Symbol	fra/49BA
Website	https://beonemedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.51%
EV Earnings	59.3x
EV/EBIT	45.38x
EV/EBITDA	36.37x
EV/FCF	27.29x
EV/Sales	5.41x
FCF yield	3.28%
Forward P/E	42.67x
P/B ratio	7.14x
P/E ratio	66.26x
P/S ratio	5.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.95%
EBITDA Margin	14.38%
FCF margin	19.42%
Gross margin	88.31%
Gross Profit	EUR 4.4B
Gross Profit Growth	43.11%
Gross Profit Growth Q	41.37%
Gross Profit Growth3 Y	45.54%
Net Income	EUR 444.9M
Net Income Growth Q	17,802.13%
Pretax Margin	11.42%
Profit Margin	8.94%
Profit Per Employee	EUR 37,079
ROA	5.96
Roa5y	-8.44
ROCE	10.17
ROE	12.42
Roe5y	-20.17
ROIC	53.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	27.98%
Cagr1y	29.83%
Cagr3y	5.8%
Cagr5y	0.6%
EPS Growth Q	16,970.8
OCF Growth	505.99%
OCF Growth Q	356.73%
Revenue Growth	37.44x
Revenue Growth Q	35.46x
Revenue Growth3 Y	54.47x
Revenue Growth5 Y	46.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.8
Assets	EUR 7.4B
Cash	EUR 4.2B
Current Assets	EUR 5.6B
Current Liabilities	EUR 1.5B
Debt	EUR 996.4M
Debt EBITDA	EUR 1.34
Debt Equity	EUR 0.24
Debt FCF	EUR 1.03
Equity	EUR 4.1B
Interest Coverage	8.15
Liabilities	EUR 3.3B
Long Term Assets	EUR 1.8B
Long Term Liabilities	EUR 1.8B
Net Cash	EUR 3.2B
Net Cash By Market Cap	EUR 10.72
Net Cash Growth	139.72%
Net Debt EBITDA	EUR -4.41
Net Debt Equity	EUR -0.77
Net Debt FCF	EUR -3.27
Tangible Book Value	EUR 4.1B
Tangible Book Value Per Share	EUR 36.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.64
Inventory Turnover	1.14
Net Working Capital	EUR 116.9M
Quick ratio	3.17
Working Capital	EUR 4.2B
Working Capital Turnover	EUR 1.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,078.22%
1Y total return	29.81%
200-day SMA	272.8
3Y total return	18.42%
50-day SMA	255.9
50-day SMA vs 200-day SMA	50under200
5Y total return	3.05%
All Time High	370
All Time High Change	-27.03%
All Time High Date	2021-09-17
All Time Low	20.77
All Time Low Change	1,200.01%
All Time Low Date	2016-02-16
ATR	7.37
Ch YTD	4.65
High	270
High52	322
High52 Date	2025-11-13
High52ch	-16.15%
Low	270
Low52	185
Low52 Date	2025-05-12
Low52ch	45.95%
Ma50ch	5.52%
Price vs 200-day SMA	-1.03%
RSI	58.05
RSI Monthly	56.26
RSI Weekly	51.25
Sharpe ratio	0.73x
Sortino ratio	1.2
Total Return	-8.16%
Tr YTD	4.65
Tr1m	4.65%
Tr1w	6.3%
Tr3m	-8.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 594.9M
Operating Income Growth Q	2,151
Operating margin	11.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,053,286%
Net Borrowing	128,466,243
Shares Qo Q	0.34%
Shares Yo Y	8.16%
Short Ratio	4.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 499.5M
Average Volume	6.2x
Bv Per Share	37.16
CAPEX	EUR -147.6M
Ch10y	1,078.2
Ch1m	4.65
Ch1w	6.3
Ch1y	29.81
Ch3m	-8.16
Ch3y	18.42
Ch5y	3.05
Ch6m	-0.74
Change	3.85%
Change From Open	0
Close	260
Days Gap	3.85
Depreciation Amortization	118,250,844.8
Earnings Date	2026-04-15
EBIT	EUR 594.9M
EBITDA	EUR 715.9M
EPS	EUR 3.82
F Score	7
FCF	EUR 966.7M
FCF EV Yield	3.66x
Financing CF	1,007,681,178
Fiscal Year End	December
Founded	2,010
Graham Number	58.88107
Graham Upside	-78.19
Income Tax	EUR 123.3M
Investing CF	-173,220,625
Is Primary Listing	0
Last Earnings Date	2026-04-15
Last Report Date	2026-03-31
Ma150	274.3
Ma150ch	-1.56%
Ma20	259.9
Ma20ch	3.89%
Net CF	2,014,593,928
Next Earnings Date	2026-08-31
Open	270
P FCF Ratio	30.5
P OCF Ratio	26.46
Ppne	1,514,812,036.2
Price Date	2026-05-08
Price EBITDA	EUR 41.18
Ptbv Ratio	7.23
Relative Volume	11.39x
Revenue	4,977,601,222x
SBC By Revenue	9.39x
Share Based Comp	467,243,998
Tax By Revenue	2.48x
Tax Rate	21.7%
Tr6m	-0.74%
Z Score	5.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/49BA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/49BA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/49BA?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/49BA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.0

Neutral momentum band

Price vs 200-day MA

-1.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/49BA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/49BA stock rating?

fra/49BA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/49BA analysis?

The full report lives at /stocks/fra/49BA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/49BA?

The latest report frames fra/49BA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/49BA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.